Teng-Yu Lee

24PUBLICATIONS
32CO-AUTHORS
Gene and molecular therapyDisease surveillancePredictive and prognostic markersMedical biochemistry - proteins and peptides (incl. medical proteomics)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 27, 2026
Tenofovir Alafenamide Versus Entecavir as Switch Therapy After Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B.

|Feb 11, 2026
Validated Nationwide Scoring System for Hepatocellular Carcinoma Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Teng-Yu Lee, Sherlot Juan Song, Hsiu J Ho

|Feb 08, 2026
Liver Steatosis-Related Polygenic Risk Score Predicts Hepatocellular Carcinoma Risk After Hepatitis C Virus Eradication.

Yu-Sheng Lin, Ying-Cheng Lin, Yun-Yu Chen

|Jan 28, 2026
Serum Outperforms Plasma for Glypican-3 Quantification in Hepatocellular Carcinoma-A Prospective Comparative Study.

Ming-Tze Yang, Jiunn-Min Wang, Chen-Shiou Wu

|Sep 27, 2025
CRAFITY and AFP/PIVKA-II Kinetics Predict Prognosis in Hepatocellular Carcinoma on Immunotherapy.

Shou-Wu Lee, Yi-Jie Huang, Ying-Cheng Lin

|May 14, 2025
The Triglyceride-Glucose Index as a Biomarker for Insulin Resistance Following Hepatitis C Virus Eradication: A Prospective Cohort Study.

Shih-Hsiung Shen, Hsin-Ju Tsai, Yu-Hsuan Li

Pageof 4

Frequent Collaborators

7 joint publications

Shou-Wu Lee

4 joint publications

Hsin-Ju Tsai

2 joint publications

Ya-Wen Chuang

2 joint publications

Yao-Chun Hsu